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Abstract
Dyspahgia in patients with malignant mesothelioma is usually due to direct infiltration of the
eosophagus by the tumour. It can be distressing for the patient and challenging for the physician to
treat. We describe three cases in which this condition has been successfully palliated with self
expanding esophageal stents.
Introduction
The incidence of malignant pleural mesothelioma (MM) is
rising rapidly in many countries and it continues to be a
challenging clinical problem. Dysphagia complicating the
disease is due to direct esophageal extension of the tumor
and has been infrequently described [1-3]. In these cases,
dysphagia has been a late complication and usually a termi-
nal event. There is only one reported case of attempted sur-
gical palliation with an endo-oesophageal tube placed
under general anesthetic via a gastrotomy [4].
Over recent years, we have acquired extensive experience in
the use of endoluminal self expanding metal stents (SEMS)
via endoscopy of the oesophagus for palliation of esopha-
geal malignancy and for benign strictures. In this report, we
describe a series of patients with MM presenting with dys-
pahgia and treated by esophageal SEMS.
Case presentation
Patient 1
A 79 year old gentleman with a history of previous asbestos
exposure presented with left sided pleural effusion in Feb-
ruary 2000. He underwent VATS drainage of the effusion
and a pleural biopsy which confirmed a diagnosis of MM
(epitheliod type). He was treated by radiotherapy and
remained well till July 2001 when he presented with dys-
phagia. CT confirmed esophageal extension of the tumour
and at endoscopy narrowing of the esophagus from 15 to
30 cm was observed. A 15 cm SEM was inserted. The SEM
was deployed in a satisfactory position but only had a slit
like opening therefore we decided to perform balloon dila-
tation within the stent.
Balloon dilatation was performed under fluoroscopic guid-
ance. A 50 mm balloon was positioned across the narrowed
region of the stent. The balloon was inflated up to 3 atmos-
pheres pressure until a satisfactory lumen within the stent
was observed. A water soluble contrast swallow was per-
formed after the procedure.
The patient was discharged and was well for 4 months
before presenting again with dysphagia and weight loss. At
endoscopy, the previous stent was patent, however a new
section of oesophagus distal to the stent was narrowed. This
was dilated with to 17 mm with Savary-Gillard dilators and
a new SEMS placed from inside the original stent extending
into the stomach. He was discharged from hospital but
died 8 months later without any further dysphagia.
Patient 2
A 67 year old gentleman, with a history of previous asbes-
tos exposure, presented with weight loss dyspnoea and left
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sided chest pain in September 2002. Chest x-ray showed a
left sided pleural effusion. CT confirmed the effusion and
pleural thickening extending into the mediastinum and
revealed para cardiac lymph nodes. In December 2002, He
had a bronchoscopy and VATS drainage of the effusion and
talc pleurodesis. Pleural fluid cytology and pleural biopsies
confirmed sarcomatoid MM.
He was treated with radiotherapy to the chest wall and
remained well until June 2003 when he presented with pro-
gressive dysphagia. CT showed tumour invading the
esophagus and endoscopy showed extrinsic compression
of the oesophagus from 30 to 40 cm. A 10 cm SEM was
inserted. He survived a further 6 months with good level of
activity and no stent related complications.
Patient 3
68-year-old gentleman diagnosed with epitheliod type MM
involving the right pleura in January 2005. He developed
dysphagia and weight loss in August 2005 and had an
endoscopy, which showed extrinsic compression of the
esophagus from 25 to 40 cm (Figure 1). He had a SEMS
deployed. At the time due to persistent narrow stent aper-
ture, balloon dilation within the stent was also performed.
He was readmitted 1 month later with further dysphagia. A
repeat endoscopy revealed a food bolus obstruction within
a widely patent stent, which was removed. He survived for
a further 1 month with no further SEM complications.
Discussion
Technically, the use of SEMS in the setting of malignant
pleural mesothelioma presents several unique challenges.
Firstly because there is usually infiltration of long segments
of the oesophagus, long stents and occasionally multiple
SEMS may be required. Secondly because the oesophagus is
infiltrated externally and becomes contiguous with a large
tumour mass throughout the mediastinum, esophageal
expansion during stent deployment is limited. We have
usually attempted to treat this by balloon dilatation of the
stent after it has been deployed.
Finally because the underlying disease is progressive, fur-
ther stenting of previously unaffected section of the esopha-
gus through patent SEMs may be required.
Dysphagia is a rare but recognized complication of malig-
nant mesothelioma. It is usually a very late feature and is
usually a terminal event. With more aggressive treatment
for malignant mesothelioma, and patients living longer
with the diagnosis, this complication may become more
common. The average length of survival after diagnosis
with malignant mesothelioma in symptomatic patients is
14.7 months [5,6]. The group of patients in this report lived
for 6, 8, and 2 months after stent placement. They had a
good quality of life and few stent related complications.
After stent insertion all 3 patients gained weight indicating
that rapid weight loss was not necessarily due to metastatic
dissemination of tumour but may in part be due to local
effects.
In conclusion, this report shows that active treatment of
dysphagia in patients with malignant mesothelioma is ben-
eficial to patients even in the presence of disseminated dis-
ease and should therefore be considered in all cases.
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CT scan showing extensive mesothelioma of the chest wall  and esophagus Figure 1
CT scan showing extensive mesothelioma of the chest wall 
and esophagus.